SPOT-studies overview

The SPOT-studies aim to improve the quality of care for women with hypertensive disorders of pregnancy. We have four overall objectives:

  1. To externally validate the fullPIERS and miniPIERS prediction models, and develop a simple, user friendly, numeric Severe Pre-eclampsia adverse Outcome Triage (SPOT) score to assist clinical decision making in severe early pre-eclampsia (SPOT-VAL).
  2. To quantify the relationship between fetal (and maternal) APOL1 status and preeclampsia and assess whether this can predict pre-eclampsia (SPOT-BIO).
  3. To understand the views on ‘good care’ of various stakeholders in the care of Hypertension Disorders in Pregnancy (HDP): health professionals, health management and pregnant women themselves.
  4. To assess impact of SPOT-score combined with shared-decision making tool implementation (SPOT-impact).
  5. To assess the incidence of mental health disorders among women with pregnancies complicated by an early HDP.

The SPOT-studies are funded by: the Bill & Melinda Gates Foundation, Dutch Research Council (NWO), University of Tennessee and the UMC Utrecht; with extensive in-kind support from all consortium members. 

For information about the study’s progress and what’s new:
Sign up for our monthly NEWSLETTER!

Here are our previous newsletter editions:

October 2019
November 2019
December 2019
January 2020
February 2020
March 2020
November 2020
April 2021
September 2021
November 2021
December 2021
February 2022 special edition
March 2022 special edition

SPOT ANIMATION

This Animation was carefully curated by the SPOT Study Team. The video provides an overview of the SPOT Study providing vital information about procedure of the Study and also taking note of Frequently Asked Questions (FAQ) during recruitment process.